- Open Access
Mapping of lymphatic filariasis in Nepal
© Sherchand et al; licensee BioMed Central Ltd. 2003
- Received: 26 February 2003
- Accepted: 19 March 2003
- Published: 19 March 2003
Human infection with Wuchereria bancrofti causes a disabling parasitic disease known as lymphatic filariasis, which is a major public health and socio-economic problem in many parts of the world. At the onset of the study, little was known of the distribution of filariasis and its current importance as a public health problem in Nepal.
Epidemiological mapping was undertaken to determine the prevalence of infection by Wuchereria bancrofti in 37 districts of Nepal between July to December 2001. The study population above 15 years of age was selected, and the immunochromatographic test (ICT Filariasis) was used to screen for circulating filarial antigen (CFA).
The overall prevalence of lymphatic filariasis from a 4,488-sample population was 13% and 33/37 districts were found to be endemic. On the basis of geographical data, the highest number of cases was found at altitudes between 500–700 m; however, a substantial number of infected individuals were found in the highly populated Kathmandu valley, at altitudes between 900–1,500 metres where transmission appears to take place. Prevalence rates above 20% were found in 11 districts (with the highest rate of 40%), 6–19% were found in 15 districts, and 0.1–5% were in 7 districts.
Information on people's knowledge, attitudes and behaviour towards filariasis was also collected by means of a structured questionnaire, which is presented and discussed in the study.
This is the most extensive study of lymphatic filariasis undertaken to date in Nepal. The study indicates that the prevalence of infection is far greater that was previously reported and that lymphatic filariasis should be a much higher health priority than currently given.
- Lymphatic Filariasis
- Kathmandu Valley
Lymphatic filariasis (LF) is disabling parasitic disease that has been identified by the World Health Organization (WHO) as a major public health problem with an increasing prevalence worldwide . At present, 1.1 billion people (20% of the world's population) in some 80 endemic countries located in tropical areas of the world are at risk of infection by Wuchereria bancrofti and Brugia malayi. Over one third of the population at risk lives on the Indian sub-continent with an estimated 45 million infected individuals .
Approximately one third of infected individuals present with overt clinical manifestations: lymphoedema and elephantiasis of the limbs or genitals, hydrocoele, chyluria, pneumonitis, or recurrent infections associated with damaged lymphatics; the remainder are at the pre-clinical stage of infection (most often with microfilaria in their blood). To this burden of disease, must also be added the serious psychosocial consequences that these profoundly disabling lesions often have. The disease is thought to be caused primarily by adult worms living in the lymphatic vessels; the microfilariae released by the female worms circulate in the peripheral blood and are not harmful, but can be ingested by mosquitoes, which transmit the infection from person to person.
Diagnosis of bancroftian filariasis relied until recently almost exclusively on the detection and identification of microfilariae in night blood specimens [3, 4]. The reason for this is that, in most geographical areas, W. bancrofti microfilariae have a natural periodicity, with highest intensity in the peripheral blood at night and few or none during the day . The other alternative test is a DEC provocation test, where the suspected patient is given a single oral dose of 50–100 mg of diethylcarbamazine (DEC is a safe drug, normally used for the treatment for LF), followed by a blood sample 30–45 minutes later: this procedure can "flush out" microfilaria into the peripheral blood during day time and has a sensitivity that is almost comparable to that of night blood surveys [6, 7]. Tests based on detection of specific W. bancrofti circulating filarial antigen (CFA) have been highly successful and a number of kits have recently become commercially available. The high specificity and sensitivity of the test has been confirmed in a number of studies [8–10]. More recently, ICT Diagnostics in Australia produced a simple immunochromatographic card test (AMRAD ICT) for the detection of circulating filarial antigen in serum and whole blood specimens [10, 11]. In this test, antigen capture is accomplished by a monoclonal antibody with high sensitivity and specificity to adult W. bancrofti antigen . The test is rapid and requires no equipment, which makes it suitable for use in many endemic areas in the developing world. In Nepal, no national study on the prevalence and distribution of lymphatic filariasis has been previously attempted, apart from a limited epidemiological survey in semi-urban areas of the central part of country [12–14], which established that LF was endemic. We carried out a study in different districts of Nepal to obtain baseline data on the prevalence of filariasis using the immunochromatographic test (ICT) for CFA detection together with a questionnaire and a clinical evaluation of cases, as a preliminary step for developing a strategy to eliminate lymphatic filariasis from Nepal.
Nepal is administratively subdivided into 75 districts, of which 58 districts (20 districts are in the Terai region and 38 are hill districts) are potentially endemic for filariasis; the 17 remaining districts are in mountainous regions and unlikely to be endemic since transmission does not normally occur above 2,000 meters. This preliminary study was designed to establish the approximate extent of the lymphatic filariasis problem in Nepal and provide the justification for further investigation and eventually future intervention programmes.
The study was undertaken over a period of 6 months from July to December 2001 in 37 districts, selected from the 58 potentially endemic districts. Village development committees (VDCs) are the smallest administrative entity in Nepal; we selected two or three VDCs for each district. Random selection was not feasible in these communities. The aim of the study was explained to the villagers and a request was made for volunteers to come forward. Every subject was informed of the purpose of the study and his or her consent was obtained. The study was approved by the Ethical and Research Committees of the Nepal Health Research Council.
The survey consisted of a questionnaire and a blood sample for parasitological examination and CFA testing. We aimed to select 100 volunteers over 15 years of age per VDC; however, in view of the dispersed nature of most communities tested, the study sample per VDC was usually reduced to 50–60 (hence the decision to test 2–3 VDCs per district). Apart from the target age (above 15 years of age in this study rather than school-age children), this procedure is comparable to the Lot Quality Assurance Sampling (LQAS) or the Rapid Geographical Assessment of Bancroftian Filariasis (RAGFIL) used in other studies to estimate endemicity [15–19].
Before blood sampling all individuals who participated were interviewed, using a structured questionnaire, on their knowledge, attitude and behaviour in relation to filariasis. A record of age, sex, occupation, educational status, medical history, birthplace, travel history, and use of bednet/number of bed nets used in the household, was kept. All participants were examined with the help of the local health worker for signs of clinical filariasis i.e. elephantiasis (lymphoedema), presence of non-pitting oedema, scrotal swelling (hydrocele), breast swelling and hand swelling.
Circulating filarial antigen screening
50–100 samples were tested from two or three VDCs from each district using the ICT card; the total % of positive for these samples was taken as the prevalence rate for that district. Two technicians worked together in this survey: one technician collected finger prick blood using a sterile lancet and a capillary tube, which was filled up to the mark of 100 μl; immediately after, the other technician performed the ICT according to manufacturer's instructions. After the blood sample was taken, the participants were asked to wait for the results. The ICT card was checked after 10 minutes looking for two lines (C and T) in the viewing window: any visible line in the T area indicates a positive test result and the test was considered negative if only the C line appeared. The test was discarded as invalid, and repeated, if either no lines appeared, or only the T line appeared (i.e. without a C line).
Whenever possible, night blood collections were made from 23.00 PM- 2.00 AM. Sixty microliters of finger-pricked blood were drawn for thick blood film, air dried, then stained with Giemsa solution (dilution 1 in 20) for 15–20 minutes. The parasites were examined and counted after returning to the laboratory  and results compared to the ICT results.
DEC provocation test
Some patients in the study were given a single oral dose of 50 mg of diethylcarbamazine (DEC), followed by a 2nd blood sample collection 30 minutes later. This procedure enabled visualisation of parasites in situations where night sampling was not acceptable and was used as quality control for the ICT. A thick blood film was prepared, air-dried, stained and examined as for the parasitological test.
The data were analyzed by using SPSS 10.00 for entire study http://www.spss.com/.
A GPS record of the geographical location of all study areas was taken and will be used in future to analyse the topographic distribution of lymphatic filariasis and develop prediction maps. In this preliminary study, information has been applied to a distribution of ICT positive cases in relation to altitude.
District-wise prevalence of lymphatic filariasis
District-wise prevalence of lymphatic filariasis in Nepal
Age and sex-wise distribution of antigenaemia
Chronic clinical filariasis
The chronic conditions of lymphatic filariasis, namely elephantiasis (lymphoedema) and hydrocele, were prevalent in the study population. Elephantiasis alone was recorded in 94 males and 127 females. 71 males were affected by more than one sequelae of lymphatic filariasis (e.g. elephantiasis and hydrocele). Breast swelling and hand swelling was also observed. While these figures are an indication of a substantial disease burden in the communities examined, they do not accurately reflect the level of burden since the study was only performed on volunteers, rather than on a random survey basis.
Parasitology and DEC provocation test
Distribution of microfilaria among different samples
Description of samples
Thick smear- DEC provocation test
Thick smear-night blood examination: (at 23:00 to 2.00 AM)
ICT positive samples (n = 216)
ICT negative samples (n = 52)
Total samples (n = 268)
The number of positives in ICT according to density of microfilariae as determined by thick blood film.
Density of microfilariae
Geographical origin (Birth place)
The respondents were asked about their birthplace, 84.4% were local people and 15.6% had migrated from elsewhere; filariasis prevalence was 12.4 % and 16.2% for local and migrants, respectively. If the respondents were not from the locality, questions were asked about their origin and travel history within the year. Nearly 44% people said that they had visited other places, mainly Terai/India where they had spent at least one week. There was no statistically significant difference in ICT positivity between the group who had a travel history and the group who did not (P > 0.005).
Geographical distribution of lymphatic filariasis
Treatment received for filariasis, leprosy and tuberculosis
Individuals taking part in the study were asked about taking anti-filarial drugs and 2.5% mentioned that they had taken medicine whereas 97.5% replied negatively. Questions regarding treatment history for leprosy and tuberculosis (TB) within the previous two years indicated that only 4% had been treated for TB or leprosy. The distribution of CFA amongst those who had been treated for TB or leprosy and those not treated was found to be highly significant (P < 0.005): ICT positivity was 13% (578/4,312) amongst the people who did not receive any treatment for TB or leprosy compared to only 2% (4/176) amongst those who had received treatment recently.
Knowledge of lymphatic filariasis
During the study period, the sample population was asked about their knowledge of lymphatic filariasis. Most of the people recognized the signs of lymphatic filariasis particularly elephantiasis by their social experience, but they had inadequate knowledge of recognition of adenolymphangitis (ADL), hydrocele, arm swelling and breast swelling as a disease of lymphatic filariasis. Of the total respondents (1,754 out of 4,488 individuals included in the study), 49.3% said that filariasis was caused by mosquito bites, 15% mentioned flies and insects, 5% blamed bad weather, 5.6% blamed poor living status, 7.5% believed that evil spirits were responsible and 9.6% did not know.
In most rural areas, where people face many health problems, there is a general tendency to first consult the traditional healer, locally called "Dhami/Jhankri". In this study, of a total of 4,488 respondents, 30% consulted traditional healer, 38% consulted modern medicine practitioner (health assistant, doctor, nurse or private practioners), 22% used herbal medicine for self-treatment and 10% did not seek any treatment.
In answer to questions regarding other diseases, 2,625 (58.5%) replied that they were suffering from other diseases.
Use of bed-nets
Of the total number of respondents, nearly 40% people mentioned that they used bed-nets in their household. Based on the questionnaire, there was no significant difference between bed-net users and non-users with regards to the clinical signs of filarial disease, but higher ICT rates were found among non bed-net users.
Lymphatic filariasis has been identified as a potentially eradicable disease [18, 21] and the 50th World Health Assembly 1997 passed a resolution that 'elimination of lymphatic filariasis as a public health problem' should be considered a priority by member states . Delimitation of endemic localities is an essential prerequisite for planning control or elimination programmes.
The present study, in different districts of Nepal, indicates lymphatic filariasis constitutes a widespread public health problem in the country. Out of a total of 37 districts studied, 11 districts were found to have a prevalence above 20%, the highest observed rate being 40%. The finding of CFA positives (and clinical cases) in the Terai region (at an altitude between 70 and 300 metres) was to be expected in view of the rate of infection previously reported from neighbouring districts of India (e.g. 13.8% positivity in Northern Bihar) , but it is worth observing that the prevalence rates found in Eastern Terai districts were generally much lower (negative in Saptari, Ilam and Mahottari districts). Perhaps the most important finding in this preliminary study was the high prevalence observed in hill districts (the highest altitude tested was 1,400 metres), which was not explained by migration of population from Terai districts: this finding is important since Kathmandu valley is the most populated area of Nepal and CFA prevalence was particularly high in the VDCs tested in that area (e.g. 20% in Kathmandu and Bhaktapur, 26% in Kavre). These findings are in keeping with Jung's survey , which had indicated a prevalence of 25% in a small sample of the population and had identified Culex (Cx.) quinquefasciatus as the main vector in all the surveyed areas. A small study conducted by Pradhan et al.,  in Gokarna VDC of Kathmandu valley reported more than 12% of microfilarial infection in the community and 12 species of mosquitoes have been identified (i.e. Anopheles (A.) nigerrimus, A, vagus, A. willmori, A. kessele, Culex (Cx.) fuscocephala, Cx. gelidus, Cx. psedovishnui, Cx. quinquefasciatus, Cx. sinensis, Cx. vishuni, Cx. whitmori and Cx. tritaeniorhynchus); in this study Cx. quinquefasciatus was also found to be the predominant species. In another VDC of Kathmandu valley (Tokha-Chandeshwori VDC), a night blood survey of 978 villagers showed a prevalence of 5.8% microfilaria by thick blood films and 9.6% of villagers were found to present clinical signs and symptoms of filariasis . It will be necessary, in further studies, to define the precise geographical limits of the endemic zone (particularly the maximal altitude, since many of Nepal districts are mountainous) and whether transmission occurs in urban areas as well as rural areas. Others have suggested that an increased prevalence of the disease may be a consequence of changes in the demographic characteristics of at-risk countries. Crowded living conditions, housing quality, and inadequate waste disposal and sanitation facilities combined with seasonal migration between endemic rural areas and non-endemic urban areas have all been shown to contribute to the growing "urbanization" of the disease [23, 24].
Lymphatic filariasis occurs in individuals of all ages and both sexes but prevails in those of low socioeconomic status . As the chronic manifestations of lymphatic filariasis appear most frequently later in life, clinical and pathological investigations have focused on the adult population. Our present study indicates that the prevalence of chronic forms of lymphatic filariasis is age-dependent in both sexes, but generally higher in males than in females. This observation is in keeping with similar studies of chronic filarial conditions from South India [25, 26] and Varanasi, North India [27, 28]. Hydrocele was the most frequent clinical sign, while elephantiasis of the leg was comparatively rare.
In this study, the use of the ICT filariasis test for the detection of antigenaemia proved of high sensitivity and efficiency. When ICT was compared to night blood samples and day samples after DEC provocation, the results were predictably twice as high as parasitology, in keeping with published validation studies of ICT, which had shown thick film to be of low sensitivity. The prevalence rates observed need to be considered with caution because of the non-random nature of the survey technique: while such information is sufficient for defining endemicity of intervention units, more accurate prevalence rates will need to be determine in selected sentinel sites to be used for monitoring future elimination programmes. It is of interest to note that this survey has provided sufficient information for advocacy purposes which has resulted in the publication of a National Programme for the Elimination of Filariasis in Nepal in April 2002.
In the context of this preliminary survey, the finding of significantly lower ICT rates in individuals receiving TB or leprosy treatment (2% compared to 13% in non-treated individuals) merits discussion in view of the recently described relationship between Wolbachia infection and filarial survival : long-term antibiotherapy, such as is given for the treatment of tuberculosis, would be the sort of intervention needed to eliminate adult worms by destroying their Wolbachia symbionts. The observation of significantly higher ICT rates in households not using bed-nets is also noteworthy. Both observations emphasize the need for further studies looking at possible interactions and cross-benefits between different national intervention programmes.
We are grateful to the Liverpool Lymphatic Filariasis Support Centre http://www.filariasis.org.uk/ for funding the study, the WHO Filariasis Programme http://www.filariasis.org/ for providing the ICT tests, Dr. Mahendra B. Bista ex. Director of Ministry of Health Epidemiology and Disease Control Division Nepal for his support and encouragement during field study activities. We thank our staff of the Infectious and Tropical Disease Research and Prevention Centre/ Nepal: Mr. Biswa Kafle, Mrs. Sarala Sherchand, Mrs. Bishnu Thakali, Mr. Ashok Chaudhary, Mr. Govinda Gurung, Mr. Jaya Singh Badal, Dr. Dirgh Singh Bam, Dr. Shushil K. Shakya and all districts health officers, VDCs chairman of study areas of Nepal.
- WHO: Lymphatic filariasis: the disease and its control. World Health Organization Geneva: Technical Report Series. 1992, 821: 1-71.Google Scholar
- Michael E, Bundy DAP, Grenfell BT: Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology. 1996, 112: 409-428.View ArticlePubMedGoogle Scholar
- McMahon JE, Magayauka SA, Kolstrup N, Mosha FW, Bushrod FM, Abaru DE, Bryan JH: Studies on the transmission and prevalence of Bancroftian filariasis in four castal villages of Tanzania. Ann Trop Med Parasitol. 1981, 75: 415-431.PubMedGoogle Scholar
- Nicolas L: New tools for diagnosis and monitoring of bancroftian filariasis parasitism: the Polynesian experience. Parasitol Today. 1997, 13: 370-375. 10.1016/S0169-4758(97)01125-3.View ArticlePubMedGoogle Scholar
- Simonsen PE, Meyrowitsch DW: Bancroftian filariasis in Tanzania: species antibody responses in relation to long-term observations on microfilaremia. Am J Trop Med Hyg. 1998, 59: 667-672.PubMedGoogle Scholar
- Sasa M, Oshima T, Sato K., Mitsui G, Sugata F, Nishi S, Yamamoto H, Tada I, Motoi E: Studies on epidemiology and control of filariasis: observations on the carriers of Wuchereria bancrofti in the Arami islands with special reference to the effects and side reactions of diethylcarbamazine. Jap J Exp Med. 1963, 33: 213-243.PubMedGoogle Scholar
- Manson-Bahr PEC, Wijers DJB: The effect of a small dose of diethylcarbamazine on the circulation of microfilariae of Wuchereria bancrofti. Trans R Soc Trop Med Hyg. 1972, 66: 18-View ArticlePubMedGoogle Scholar
- More SJ, Copeman DB: A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis. Trop Med Parasitol. 1990, 41: 403-406.PubMedGoogle Scholar
- Chanteau S, Glazious P, Plichart C, Luquiaud P, Mouliapelat JP, Nguyen L, Cartel JL: Wuchereria bancrofti filariasis in French Polynesia: age-specific patterns of microfilaremia, circulating antigen, and specific IgG and IgG4 responses according to transmission level. Int J Parasitol. 1995, 25: 81-85. 10.1016/0020-7519(94)00088-6.View ArticlePubMedGoogle Scholar
- Weil GJ, Lammie PJ, Weiss N: The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today. 1997, 13: 401-404. 10.1016/S0169-4758(97)01130-7.View ArticlePubMedGoogle Scholar
- Phantana S, Sensathein S, Songtrus J, Klagrathoke S, Phongnin K: ICT Filariasis test: A new screening test for bancroftian filariasis. Southeast Asian J Trop Med Public Health. 1999, 30: 47-51.PubMedGoogle Scholar
- Jung RK: A brief study on the epidemiology of filariasis in Nepal. Journal Nepal Medical Association. 1973, 11: 5-6.Google Scholar
- Pradhan SP, Shrestha I, Palikhey N, Uprety RP: Epidemiological study of lymphatic filariasis in Gokarna village development committee of Kathmandu valley during August and September, 1997. J Nepal Hlth Res Council. 1998, 2: 13-17.Google Scholar
- Bhusal KP, Joshi AB, Mishra PN, Bhusal K: Prevalence of Wuchereria bancrofti infections in Tokha-Chandeshwori Village Development Committee, Kathmandu, Nepal. J Institute Med. 2000, 22: 13-19.Google Scholar
- Gyapong JO, Kyelem D, Kleinschmidt I, Agbo K, Ahouandogbo F, Gaba J, Owusu-Banahene G, Sanou S, Sodahlon YK, Biswas G, Kale OO, Molyneux DH, Roungou JB, Thomson MC, Remme J: The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries. Ann Trop Med Parasitol. 2002, 96: 695-705. 10.1179/000349802125001735.View ArticlePubMedGoogle Scholar
- Gyapong JW, Adjei S, Gyapong M, Asamoah G: Rapid community diagnosis of lymphatic filariasis. Acta Trop. 1996, 61: 65-74. 10.1016/0001-706X(95)00141-Z.View ArticlePubMedGoogle Scholar
- Ottesen EA, Duke BOL, Karam M, Behbehani K: Strategies and tools for the control/ elimination of lymphatic filariasis. Bull World Health Organ. 1997, 75: 491-503.PubMed CentralPubMedGoogle Scholar
- WHO: Lymphatic filariasis: reasons for hope. Geneva: World Health Organization 1997. WHO/CTD/FIL/97.4. 1997Google Scholar
- Srividya A, Lall R, Ramaiah KD, Hoti SL, Pani SP, Das PK: Development of rapid assessment procedures for the delimitation of lymphatic filariasis-endemic areas. Trop Med Int Health. 2000, 5: 64-71. 10.1046/j.1365-3156.2000.00515.x.View ArticlePubMedGoogle Scholar
- Denham DA, Dennis DT, Ponnodurai T, Nelson GS, Guy F: Comparison of a counting chamber and thick blood smear methods of counting microfilariae. Trans R Soc Trop Med Hyg. 1971, 65: 521-526.View ArticlePubMedGoogle Scholar
- Centre for Disease Control: Recommendations of the International Task Force for Disease Eradication. Morb Mortal Wkly Rep. 1993, 42: 1-38.Google Scholar
- Sabesan S, Palaniyandi M, Das PK, Michael E: Mapping of lymphatic filariasis in India. Ann Trop Med Parasitol. 2000, 94: 591-606.PubMedGoogle Scholar
- Schweinfurth U: Filarial disease in Ceylon: a geographical and historical analysis. Ecology and Disease. 1983, 2: 309-319.Google Scholar
- Mak JW: Problems in filariasis control and the need for human behaviour and socio-economic research. Southeast Asian J Trop Med Public Health. 1986, 17: 479-485.PubMedGoogle Scholar
- Pani SP, Balakrishnan N, Srividya A, Bundy DAP, Grenfell BT: Clinical epidemiology of bancroftian filariasis: effect of age and gender. Trans R Soc Trop Med Hyg. 1991, 85: 260-264.View ArticlePubMedGoogle Scholar
- Ramaiah KD, Ramu K, Vijaykumar KN, Guyatt H: Epidemiology of acute filarial episodes caused by Wuchereria bancrofti infection in two rural villages in Tamil Nandu, South India. Trans R Soc Trop Med Hyg. 1996, 90: 639-642. 10.1016/S0035-9203(96)90415-0.View ArticlePubMedGoogle Scholar
- Sharma S, Sharma M, Rathur S: Bancroftian filariasis in the Varanasi region of north India: an epidemiological study. Ann Trop Med Parasitol. 1999, 93: 379-387. 10.1080/00034989958375.View ArticlePubMedGoogle Scholar
- Babu BV, Acharya AS, Mallick G, Jangid PK, Nayak AN, Satyanarayan K: Lymphatic filariasis in Khurda district of Orissa India: An epidemiological study. Southeast Asian J Trop Med Public Health. 2001, 32: 240-243.PubMedGoogle Scholar
- Taylor MJ: Elimination of lymphatic filariasis as a public health problem: Wolbachia bacteria of filarial nematodes in the pathogenesis of disease and as a target for control. Trans R Soc Trop Med Hyg. 2000, 94: 596-598.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.